Advanced Tissue Sciences
This article was originally published in The Gray Sheet
Executive Summary
Collaborating with Cell Genesys, Inc. on the development of a "universal, full-thickness" skin replacement product. The new product is intended to eliminate the need to harvest grafts of a patient's own skin and reduce delays associated with culturing a patient's own skin cells in the laboratory before grafting takes place. The collaboration will utilize ATS' dermal tissue engineering technology and Cell Genesys' engineered epidermal skin cells. ATS currently is in clinical trials with its Dermagraft skin replacement product for the treatment of severe burns and chronic skin ulcers....